Adjuvant therapy for women with high-risk endometrial carcinoma

Sean Christopher Dowdy, Gretchen E. Glaser

Research output: Contribution to journalComment/debate

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)268-269
Number of pages2
JournalThe Lancet Oncology
Volume19
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Endometrial Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Adjuvant therapy for women with high-risk endometrial carcinoma. / Dowdy, Sean Christopher; Glaser, Gretchen E.

In: The Lancet Oncology, Vol. 19, No. 3, 01.03.2018, p. 268-269.

Research output: Contribution to journalComment/debate

@article{baeb391ffbf34e82a44d567afdef4a6b,
title = "Adjuvant therapy for women with high-risk endometrial carcinoma",
author = "Dowdy, {Sean Christopher} and Glaser, {Gretchen E.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/S1470-2045(18)30091-3",
language = "English (US)",
volume = "19",
pages = "268--269",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "3",

}

TY - JOUR

T1 - Adjuvant therapy for women with high-risk endometrial carcinoma

AU - Dowdy, Sean Christopher

AU - Glaser, Gretchen E.

PY - 2018/3/1

Y1 - 2018/3/1

UR - http://www.scopus.com/inward/record.url?scp=85041943899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041943899&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30091-3

DO - 10.1016/S1470-2045(18)30091-3

M3 - Comment/debate

C2 - 29449190

AN - SCOPUS:85041943899

VL - 19

SP - 268

EP - 269

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 3

ER -